Sarcoidosis:疾病机制,诊断途径和治疗方法
Jelle Miedema1, Hilario Nunes2, Virgil A S H Dalm3
1Department of Pulmonary Medicine, Center of Expertise for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, the Netherlands.
Autoimmunity reviews
|February 6, 2026
概括
沙丘病是一个复杂的炎症性疾病,原因不明,经常影响肺部. 虽然有些病例会自发地消失,但另一些病例会进展,需要除了皮质类固醇之外的治疗,皮质类固醇具有显著的毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
背景情况:
- 沙丘病是一个多系统的细粒状炎症性疾病,病因不明.
- 它通常影响肺部和胸部淋巴结,但可以涉及任何器官.
- 遗传,环境和种族因素可能会导致沙尔科毒症的发展.
研究的目的:
- 为了提供有关类菌病的病原体,诊断和治疗的概述.
- 为了突出最近在理解沙尔科病的进步.
- 讨论新疗法临床试验设计中的挑战.
主要方法:
- 审查最近的免疫学研究,包括单细胞RNA测序和空间转录组学.
- 诊断标准和差异诊断的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- 诊断依赖于临床,放射学和组织病理学发现,不包括其他颗粒状疾病.
- 虽然通常是自我限制的,但沙尔科病症可以导致慢性疾病,器官衰竭或死亡,高达三分之一的患者.
- 甲托雷克萨特在肺性沙丘病中表现出与普得尼松相当的疗效;JAK和mTOR抑制剂是潜在的新疗法.
结论:
- Sarcoidosis 诊断是具有挑战性的,因为呈现的变化和缺乏一个黄金标准.
- 像皮质类固醇这样的当前治疗方法有局限性;需要新的,耐受良好的疗法.
- 类型的异质性和罕见性使临床试验设计和药物开发复杂化.
相关概念视频
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
966
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
635
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
635
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
451
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
451
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
614
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
614


